(18)F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer

There is an unmet need for predictive biomarkers of the clinical benefit of antiangiogenic drugs. The aim of the present study was to prospectively evaluate the value of (18)F-FDG PET/CT performed during and after preoperative chemoradiotherapy with bevacizumab for the prediction of complete patholo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Nucl Med
Egile Nagusiak: Avallone, Antonio, Aloj, Luigi, Pecori, Biagio, Caracò, Corradina, De Stefano, Alfonso, Tatangelo, Fabiana, Silvestro, Lucrezia, Granata, Vincenza, Bianco, Francesco, Romano, Carmela, Di Gennaro, Francesca, Budillon, Alfredo, Petrillo, Antonella, Muto, Paolo, Botti, Gerardo, Delrio, Paolo, Lastoria, Secondo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Society of Nuclear Medicine 2019
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836863/
https://ncbi.nlm.nih.gov/pubmed/30877175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.222604
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak